{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T15:09:58Z","timestamp":1792595398875,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T00:00:00Z","timestamp":1754956800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurobiology of Disease"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.nbd.2025.107057","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T21:46:15Z","timestamp":1755553575000},"page":"107057","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Retinal tau phosphorylation in Alzheimer's disease: A mass spectrometry study"],"prefix":"10.1016","volume":"215","author":[{"given":"Jessica","family":"Santiago","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dovil\u0117","family":"Pocevi\u010di\u016bt\u0117","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Vogel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Brinkmalm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malin","family":"Wennstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"12","key":"10.1016\/j.nbd.2025.107057_bb0005","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1097\/WNR.0b013e3283497334","article-title":"Retinal amyloid peptides and complement factor H in transgenic models of Alzheimer\u2019s disease","volume":"22","author":"Alexandrov","year":"2011","journal-title":"NeuroReport"},{"key":"10.1016\/j.nbd.2025.107057_bb0010","article-title":"Tau post-translational modifications: dynamic transformers of tau function, degradation, and aggregation","volume":"11","author":"Alquezar","year":"2020","journal-title":"Front. Neurol."},{"issue":"Pt 7","key":"10.1016\/j.nbd.2025.107057_bb0015","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1093\/brain\/awn119","article-title":"Abnormally phosphorylated tau is associated with neuronal and axonal loss in experimental autoimmune encephalomyelitis and multiple sclerosis","volume":"131","author":"Anderson","year":"2008","journal-title":"Brain"},{"issue":"5","key":"10.1016\/j.nbd.2025.107057_bb0020","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1007\/s00401-010-0671-4","article-title":"Abnormal tau phosphorylation in primary progressive multiple sclerosis","volume":"119","author":"Anderson","year":"2010","journal-title":"Acta Neuropathol."},{"issue":"9","key":"10.1016\/j.nbd.2025.107057_bb0025","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/nrn2194","article-title":"Tau-mediated neurodegeneration in Alzheimer\u2019s disease and related disorders","volume":"8","author":"Ballatore","year":"2007","journal-title":"Nat. Rev. Neurosci."},{"issue":"4","key":"10.1016\/j.nbd.2025.107057_bb0030","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.3233\/JAD-150962","article-title":"Differential mass spectrometry profiles of tau protein in the cerebrospinal fluid of patients with Alzheimer\u2019s disease, progressive Supranuclear palsy, and dementia with Lewy bodies","volume":"51","author":"Barthelemy","year":"2016","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.nbd.2025.107057_bb0035","doi-asserted-by":"crossref","first-page":"121","DOI":"10.3389\/fnagi.2019.00121","article-title":"Tau phosphorylation rates measured by mass spectrometry differ in the intracellular brain vs. extracellular cerebrospinal fluid compartments and are differentially affected by Alzheimer\u2019s disease","volume":"11","author":"Barthelemy","year":"2019","journal-title":"Front. Aging Neurosci."},{"issue":"4","key":"10.1016\/j.nbd.2025.107057_bb0040","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1083\/jcb.101.4.1371","article-title":"The distribution of tau in the mammalian central nervous system","volume":"101","author":"Binder","year":"1985","journal-title":"J. Cell Biol."},{"issue":"4","key":"10.1016\/j.nbd.2025.107057_bb0045","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol."},{"issue":"2","key":"10.1016\/j.nbd.2025.107057_bb0050","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S0197-4580(02)00065-9","article-title":"Staging of brain pathology related to sporadic Parkinson\u2019s disease","volume":"24","author":"Braak","year":"2003","journal-title":"Neurobiol. Aging"},{"issue":"4","key":"10.1016\/j.nbd.2025.107057_bb0055","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s00401-006-0127-z","article-title":"Staging of Alzheimer disease-associated neurofibrillary pathology using paraffin sections and immunocytochemistry","volume":"112","author":"Braak","year":"2006","journal-title":"Acta Neuropathol."},{"issue":"7","key":"10.1016\/j.nbd.2025.107057_bb0060","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.10.7.5","article-title":"ARCAM-1 facilitates fluorescence detection of amyloid-containing deposits in the retina","volume":"10","author":"Cao","year":"2021","journal-title":"Transl. Vis. Sci. Technol."},{"issue":"1\u20132","key":"10.1016\/j.nbd.2025.107057_bb0065","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.jns.2006.08.017","article-title":"Inflammatory demyelination and neurodegeneration in early multiple sclerosis","volume":"259","author":"Charil","year":"2007","journal-title":"J. Neurol. Sci."},{"issue":"7","key":"10.1016\/j.nbd.2025.107057_bb0070","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1038\/ncb1901","article-title":"Transmission and spreading of tauopathy in transgenic mouse brain","volume":"11","author":"Clavaguera","year":"2009","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.nbd.2025.107057_bb0075","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40478-025-01935-y","article-title":"Retinal ganglion cell vulnerability to pathogenic tau in Alzheimer\u2019s disease","volume":"13","author":"Davis","year":"2025","journal-title":"Acta Neuropathol Commun"},{"issue":"1","key":"10.1016\/j.nbd.2025.107057_bb0080","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40478-025-01935-y","article-title":"Retinal ganglion cell vulnerability to pathogenic tau in Alzheimer\u2019s disease","volume":"13","author":"Davis","year":"2025","journal-title":"Acta Neuropathol. Commun."},{"issue":"9","key":"10.1016\/j.nbd.2025.107057_bb0085","doi-asserted-by":"crossref","first-page":"2803","DOI":"10.1093\/brain\/awaa223","article-title":"Phosphorylated tau interactome in the human Alzheimer\u2019s disease brain","volume":"143","author":"Drummond","year":"2020","journal-title":"Brain"},{"issue":"4","key":"10.1016\/j.nbd.2025.107057_bb0090","doi-asserted-by":"crossref","DOI":"10.1093\/pnasnexus\/pgac164","article-title":"Label-free hyperspectral imaging and deep-learning prediction of retinal amyloid beta-protein and phosphorylated tau","volume":"1","author":"Du","year":"2022","journal-title":"PNAS Nexus"},{"issue":"11","key":"10.1016\/j.nbd.2025.107057_bb0095","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1093\/hmg\/7.11.1825","article-title":"Segregation of a missense mutation in the microtubule-associated protein tau gene with familial frontotemporal dementia and parkinsonism","volume":"7","author":"Dumanchin","year":"1998","journal-title":"Hum. Mol. Genet."},{"key":"10.1016\/j.nbd.2025.107057_bb0100","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.brainres.2017.09.030","article-title":"Aging dependent effect of nuclear tau","volume":"1677","author":"Gil","year":"2017","journal-title":"Brain Res."},{"key":"10.1016\/j.nbd.2025.107057_bb0105","doi-asserted-by":"crossref","first-page":"925","DOI":"10.3389\/fnins.2019.00925","article-title":"Neuroinflammatory processes, A1 astrocyte activation and protein aggregation in the retina of Alzheimer\u2019s disease patients, possible biomarkers for early diagnosis","volume":"13","author":"Grimaldi","year":"2019","journal-title":"Front. Neurosci."},{"issue":"13","key":"10.1016\/j.nbd.2025.107057_bb0110","doi-asserted-by":"crossref","first-page":"4913","DOI":"10.1073\/pnas.83.13.4913","article-title":"Abnormal phosphorylation of the microtubule-associated protein tau (tau) in Alzheimer cytoskeletal pathology","volume":"83","author":"Grundke-Iqbal","year":"1986","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.nbd.2025.107057_bb0115","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.dadm.2017.10.005","article-title":"Retinal thickness correlates with parietal cortical atrophy in early-onset Alzheimer\u2019s disease and controls","volume":"10","author":"den Haan","year":"2018","journal-title":"Alzheimers Dement (Amst)"},{"issue":"1","key":"10.1016\/j.nbd.2025.107057_bb0120","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s40478-018-0650-x","article-title":"Amyloid-beta and phosphorylated tau in post-mortem Alzheimer\u2019s disease retinas","volume":"6","author":"den Haan","year":"2018","journal-title":"Acta Neuropathol. Commun."},{"issue":"3","key":"10.1016\/j.nbd.2025.107057_bb0125","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.molmed.2009.01.003","article-title":"Tau phosphorylation: the therapeutic challenge for neurodegenerative disease","volume":"15","author":"Hanger","year":"2009","journal-title":"Trends Mol. Med."},{"issue":"8","key":"10.1016\/j.nbd.2025.107057_bb0130","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/jamaneurol.2019.1424","article-title":"Association of amyloid and tau with cognition in preclinical Alzheimer disease: a longitudinal study","volume":"76","author":"Hanseeuw","year":"2019","journal-title":"JAMA Neurol."},{"issue":"2","key":"10.1016\/j.nbd.2025.107057_bb0135","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s00401-022-02525-1","article-title":"Phosphorylated tau in the retina correlates with tau pathology in the brain in Alzheimer\u2019s disease and primary tauopathies","volume":"145","author":"Hart de Ruyter","year":"2023","journal-title":"Acta Neuropathol."},{"issue":"1","key":"10.1016\/j.nbd.2025.107057_bb0140","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/s00401-024-02769-z","article-title":"Neuropathological hallmarks in the post-mortem retina of neurodegenerative diseases","volume":"148","author":"Hart de Ruyter","year":"2024","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1016\/j.nbd.2025.107057_bb0145","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.neuron.2010.11.030","article-title":"Tau mislocalization to dendritic spines mediates synaptic dysfunction independently of neurodegeneration","volume":"68","author":"Hoover","year":"2010","journal-title":"Neuron"},{"issue":"3","key":"10.1016\/j.nbd.2025.107057_bb0150","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2010.06.036","article-title":"Dendritic function of tau mediates amyloid-beta toxicity in Alzheimer\u2019s disease mouse models","volume":"142","author":"Ittner","year":"2010","journal-title":"Cell"},{"issue":"16","key":"10.1016\/j.nbd.2025.107057_bb0155","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93621","article-title":"Retinal amyloid pathology and proof-of-concept imaging trial in Alzheimer\u2019s disease","volume":"2","author":"Koronyo","year":"2017","journal-title":"JCI Insight"},{"issue":"4","key":"10.1016\/j.nbd.2025.107057_bb0160","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00401-023-02548-2","article-title":"Retinal pathological features and proteome signatures of Alzheimer\u2019s disease","volume":"145","author":"Koronyo","year":"2023","journal-title":"Acta Neuropathol."},{"issue":"Suppl. 1","key":"10.1016\/j.nbd.2025.107057_bb0165","article-title":"Identification of amyloid plaques in retinas from Alzheimer\u2019s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model","volume":"54","author":"Koronyo-Hamaoui","year":"2011","journal-title":"Neuroimage"},{"key":"10.1016\/j.nbd.2025.107057_bb0170","doi-asserted-by":"crossref","DOI":"10.1016\/j.neuroimage.2010.06.020","article-title":"Identification of amyloid plaques in retinas from Alzheimer\u2019s patients and noninvasive in vivo optical imaging of retinal plaques in a mouse model","volume":"54","author":"Koronyo-Hamaoui","year":"2011","journal-title":"Neuroimage"},{"issue":"1","key":"10.1016\/j.nbd.2025.107057_bb0175","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1002\/ana.24548","article-title":"Melanopsin retinal ganglion cell loss in a lzheimer disease","volume":"79","author":"La Morgia","year":"2016","journal-title":"Ann. Neurol."},{"issue":"1","key":"10.1016\/j.nbd.2025.107057_bb0180","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s40478-022-01444-2","article-title":"Tau seeding in cases of multiple sclerosis","volume":"10","author":"LaCroix","year":"2022","journal-title":"Acta Neuropathol. Commun."},{"issue":"12","key":"10.1016\/j.nbd.2025.107057_bb0185","doi-asserted-by":"crossref","DOI":"10.15252\/emmm.202115098","article-title":"P-tau235: a novel biomarker for staging preclinical Alzheimer\u2019s disease","volume":"13","author":"Lantero-Rodriguez","year":"2021","journal-title":"EMBO Mol. Med."},{"issue":"1","key":"10.1016\/j.nbd.2025.107057_bb0190","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1186\/s13024-024-00741-9","article-title":"Tau protein profiling in tauopathies: a human brain study","volume":"19","author":"Lantero-Rodriguez","year":"2024","journal-title":"Mol. Neurodegener."},{"key":"10.1016\/j.nbd.2025.107057_bb0195","doi-asserted-by":"crossref","first-page":"758","DOI":"10.3389\/fnins.2020.00758","article-title":"Amyloid beta immunoreactivity in the retinal ganglion cell layer of the Alzheimer\u2019s eye","volume":"14","author":"Lee","year":"2020","journal-title":"Front. Neurosci."},{"issue":"1","key":"10.1016\/j.nbd.2025.107057_bb0200","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/nrneurol.2012.227","article-title":"The retina as a window to the brain-from eye research to CNS disorders","volume":"9","author":"London","year":"2013","journal-title":"Nat. Rev. Neurol."},{"issue":"4","key":"10.1016\/j.nbd.2025.107057_bb0205","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194828","article-title":"Searching for neurodegeneration in multiple sclerosis at clinical onset: diagnostic value of biomarkers","volume":"13","author":"Novakova","year":"2018","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.nbd.2025.107057_bb0210","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13195-023-01375-7","article-title":"The fluorescent ligand bTVBT2 reveals increased p-tau uptake by retinal microglia in Alzheimer\u2019s disease patients and app(NL-F\/NL-F) mice","volume":"16","author":"Nunez-Diaz","year":"2024","journal-title":"Alzheimer\u2019s Res Ther"},{"issue":"5","key":"10.1016\/j.nbd.2025.107057_bb0215","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.1021\/pr7008669","article-title":"Characterization of tau in cerebrospinal fluid using mass spectrometry","volume":"7","author":"Portelius","year":"2008","journal-title":"J. Proteome Res."},{"issue":"2","key":"10.1016\/j.nbd.2025.107057_bb0220","doi-asserted-by":"crossref","DOI":"10.1167\/tvst.9.2.47","article-title":"Predicting thioflavin fluorescence of retinal amyloid deposits associated with Alzheimer\u2019s disease from their polarimetric properties","volume":"9","author":"Qiu","year":"2020","journal-title":"Transl. Vis. Sci. Technol."},{"issue":"1","key":"10.1016\/j.nbd.2025.107057_bb0225","doi-asserted-by":"crossref","first-page":"303","DOI":"10.3233\/JAD-160633","article-title":"Comprehensive quantitative profiling of tau and phosphorylated tau peptides in cerebrospinal fluid by mass spectrometry provides new biomarker candidates","volume":"55","author":"Russell","year":"2017","journal-title":"J Alzheimer\u2019s Dis"},{"issue":"12","key":"10.1016\/j.nbd.2025.107057_bb0230","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0053547","article-title":"Long-term in vivo imaging of fibrillar tau in the retina of P301S transgenic mice","volume":"7","author":"Schon","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/j.nbd.2025.107057_bb0235","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.neurobiolaging.2018.05.003","article-title":"Levels of retinal IAPP are altered in Alzheimer\u2019s disease patients and correlate with vascular changes and hippocampal IAPP levels","volume":"69","author":"Schultz","year":"2018","journal-title":"Neurobiol. Aging"},{"issue":"3","key":"10.1016\/j.nbd.2025.107057_bb0240","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.3233\/JAD-190868","article-title":"Levels of retinal amyloid-beta correlate with levels of retinal IAPP and hippocampal amyloid-beta in Neuropathologically evaluated individuals","volume":"73","author":"Schultz","year":"2020","journal-title":"J Alzheimer\u2019s Dis"},{"key":"10.1016\/j.nbd.2025.107057_bb0245","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1007\/s00401-020-02134-w","article-title":"Identification of early pericyte loss and vascular amyloidosis in Alzheimer\u2019s disease retina","volume":"139","author":"Shi","year":"2020","journal-title":"Acta Neuropathol."},{"issue":"11","key":"10.1016\/j.nbd.2025.107057_bb0250","doi-asserted-by":"crossref","first-page":"5185","DOI":"10.1002\/alz.13086","article-title":"Retinal arterial A\u03b240 deposition is linked with tight junction loss and cerebral amyloid angiopathy in MCI and AD patients","volume":"19","author":"Shi","year":"2023","journal-title":"Alzheimers Dement."},{"issue":"1","key":"10.1016\/j.nbd.2025.107057_bb0255","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00401-024-02760-8","article-title":"Identification of retinal oligomeric, citrullinated, and other tau isoforms in early and advanced AD and relations to disease status","volume":"148","author":"Shi","year":"2024","journal-title":"Acta Neuropathol."},{"issue":"6","key":"10.1016\/j.nbd.2025.107057_bb0260","doi-asserted-by":"crossref","first-page":"4566","DOI":"10.1074\/jbc.M110.199976","article-title":"Nuclear tau, a key player in neuronal DNA protection","volume":"286","author":"Sultan","year":"2011","journal-title":"J. Biol. Chem."},{"issue":"1","key":"10.1016\/j.nbd.2025.107057_bb0265","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1167\/iovs.13-12888","article-title":"Ocular changes in TgF344-AD rat model of Alzheimer\u2019s disease","volume":"55","author":"Tsai","year":"2014","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"1","key":"10.1016\/j.nbd.2025.107057_bb0270","doi-asserted-by":"crossref","first-page":"17702","DOI":"10.1038\/s41598-018-36374-4","article-title":"Phosphorylation of nuclear tau is modulated by distinct cellular pathways","volume":"8","author":"Ulrich","year":"2018","journal-title":"Sci. Rep."},{"key":"10.1016\/j.nbd.2025.107057_bb0275","doi-asserted-by":"crossref","first-page":"84","DOI":"10.3389\/fncel.2014.00084","article-title":"A major role for tau in neuronal DNA and RNA protection in vivo under physiological and hyperthermic conditions","volume":"8","author":"Violet","year":"2014","journal-title":"Front. Cell. Neurosci."},{"issue":"3","key":"10.1016\/j.nbd.2025.107057_bb0280","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/s41592-019-0686-2","article-title":"SciPy 1.0: fundamental algorithms for scientific computing in python","volume":"17","author":"Virtanen","year":"2020","journal-title":"Nat. Methods"},{"issue":"1","key":"10.1016\/j.nbd.2025.107057_bb0285","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1002\/alz.13424","article-title":"Primary retinal tauopathy: a tauopathy with a distinct molecular pattern","volume":"20","author":"Walkiewicz","year":"2024","journal-title":"Alzheimers Dement."},{"issue":"48","key":"10.1016\/j.nbd.2025.107057_bb0290","doi-asserted-by":"crossref","first-page":"6313","DOI":"10.1039\/b705094a","article-title":"Stepwise interfacial self-assembly of nanoparticles via specific DNA pairing","volume":"9","author":"Wang","year":"2007","journal-title":"Phys. Chem. Chem. Phys."},{"issue":"1","key":"10.1016\/j.nbd.2025.107057_bb0295","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nrn.2015.1","article-title":"Tau in physiology and pathology","volume":"17","author":"Wang","year":"2016","journal-title":"Nat. Rev. Neurosci."},{"issue":"5","key":"10.1016\/j.nbd.2025.107057_bb0300","doi-asserted-by":"crossref","first-page":"1858","DOI":"10.1073\/pnas.72.5.1858","article-title":"A protein factor essential for microtubule assembly","volume":"72","author":"Weingarten","year":"1975","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"1","key":"10.1016\/j.nbd.2025.107057_bb0305","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s40478-022-01448-y","article-title":"M\u00fcller cell degeneration and microglial dysfunction in the Alzheimer\u2019s retina","volume":"10","author":"Xu","year":"2022","journal-title":"Acta Neuropathologica Commun."}],"container-title":["Neurobiology of Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125002736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0969996125002736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T06:21:02Z","timestamp":1759299662000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0969996125002736"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":61,"alternative-id":["S0969996125002736"],"URL":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107057","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2025.02.17.638688","asserted-by":"object"}]},"ISSN":["0969-9961"],"issn-type":[{"value":"0969-9961","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retinal tau phosphorylation in Alzheimer's disease: A mass spectrometry study","name":"articletitle","label":"Article Title"},{"value":"Neurobiology of Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.nbd.2025.107057","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"107057"}}